Lapatinib 250 Mg

Product Description

Description

• Each film coated tablet Contains :Lapatinib 250 MgTablet Colours Red oxide of iron Yellow oxide of iron Titanium Dioxide IP.

Doses

As Directed by physician

Indication

• Lapatinib is an anti-cancer medication.
• This works against the HER2 (human epidermal growth factor receptor protein) receptors and EGFRs (epidermal growth factor receptor) which are responsible for the over-proliferation of cells.
• This is how it inhibits the growth of cancerous cells causing downstream signaling pathways.

Targeted Cancer Therapy Solution

Lapatinib 250 mg Tablet is formulated to target certain types of cancer, offering precision in treatment due to its specific inhibition of relevant enzymes. Its oral administration supports easier compliance compared to other forms of medication, contributing to better patient outcomes during therapy cycles. The formulation adheres to stringent quality norms to provide consistent effectiveness and safety.


Optimal Storage for Maximum Effectiveness

Proper storage plays a crucial role in maintaining the potency and stability of Lapatinib tablets. To ensure the active component remains effective, tablets must be stored in a cool, dry location, away from direct sunlight, and at temperatures between 15C and 30C. Adhering to these guidelines preserves the medication's integrity for the full duration of its shelf life.